PATENT CLAIM ANALYSIS

Application Number: 16092714
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "613000"]

Abstract:
The present disclosure provides pharmaceutical compositions comprising a fatty acid amide of an amino acid as defined herein, such as oleoyl-α-methyl-serine, or a stereoisomer or salt thereof, for improving, as in increasing or preventing loss of, bone mineral density and/or treating osteoporosis in patients suffering from Prader-Willi syndrome; and their methods of use.

Claim (Index 11):
The method of  claim 10 , wherein R 10  is (C 15 )alkenyl.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.2766
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12936498', '08463771', '13390984', '14849270', '15581749']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7300473916951642
- 35 USC 102 Novelty (BERT): 0.5133828968861989
- Combined Prediction Score: 0.7083809422142676
- Mean Citation Score: 208.48455
- Max Citation Score: 237.4825
- Similarity Product: 154.88727162957193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test